Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trialF Barlesi, A Scherpereel, V Gorbunova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Molecular Tumor Boards: current practice and future needsD L van der Velden, C M L van Herpen, H W M van Laarhoven, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trialH Kievit, M B Muntinghe-Wagenaar, L B M Hijmering-Kappelle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2010
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imagingA-M C Dingemans, A J de Langen, V van den Boogaart, et al.
Plos One|August 31, 2017
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progressionA J van der Wekken, J L Kuiper, A Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2019
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profileB C M Hermans, J L Derks, E Thunnissen, et al.
Cancer Investigation|August 31, 2006
The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patientsM A Stokman, C S M Oude Nijhuis, F K L Spijkervet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III studyH J M Groen, A H W van der Leest, E Fokkema, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)B C M Hermans, J L Derks, E Thunnissen, et al.
Epigenetics|July 6, 2016
RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasisM J A M Clausen, L J Melchers, M F Mastik, et al.
Pageof 7